Clinical Trials Logo

Filter by:
NCT ID: NCT06200740 Completed - Opioid Use Disorder Clinical Trials

Remotely Observed Methadone Evaluation

ROME
Start date: September 25, 2022
Phase: N/A
Study type: Interventional

Opioid addiction, which affects 16 million individuals worldwide, can be treated using methadone, a proven and effective opioid medication for treating OUD that extends retention in care, reduces mortality, and inhibits illicit drug use. However, methadone treatment is limited to federally certified Opioid Treatment Programs (OTPs), which must meet complex regulatory requirements, and require new patients to take their dose in person six days per week, presenting significant barriers to treatment. To address these barriers, Sonara Heath has developed the Sonara software platform, which will enable OTPs to offer accelerated take-home methadone regimens while maintaining safety and diversion prevention.

NCT ID: NCT06199661 Completed - Functional Fitness Clinical Trials

High-Intensity Exercise in Older Adults

Start date: March 6, 2023
Phase: N/A
Study type: Interventional

The goal of this interventional study was to test the high-intensity interval training called Aphasia Physical Exercise (APEX) in healthy older adults. The main questions it aimed to answer were: 1. what is the safety and feasibility of APEX? 2. what are APEX's acute physiological effects? 3. what is APEX's effects on functional fitness? 4. what is APEX's effects on cognition? Participants underwent: - Baseline testing session (#1) with cognitive measures only (a week before the Pre-exercise session); - Pre-exercise session (#2) with maximum oxygen consumption and heart rate assessment, functional fitness and cognitive measures (3-7 days before the start of the exercise program); - APEX program, two APEX classes per week for four weeks (eight classes in total); - Post-exercise session (#3), functional fitness and cognitive measures, (0-2 days after the end of the exercise program).

NCT ID: NCT06197282 Completed - COVID-19 Clinical Trials

Impact of COVID-19 on Surgical Outcomes

Start date: May 5, 2020
Phase:
Study type: Observational

Following the introduction of the COVID-19 vaccination, elective surgeries have resumed, allowing for greater insight into the postoperative period and outcomes aims on-going COVID-19 infections. This study aimed to evaluate risk factors of postoperative morbidity and mortality in patients who had surgery within one year of testing positive for COVID-19.

NCT ID: NCT06195319 Completed - Metabolism Clinical Trials

Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects

Start date: February 7, 2024
Phase: Phase 1
Study type: Interventional

To evaluate the absorption, metabolism, and excretion of [14C]-simufilam in healthy male subjects following a single oral administration of 100 mg of (approximately 100 µCi) [14C]-simufilam.

NCT ID: NCT06194578 Completed - Healthy Volunteers Clinical Trials

A Study of Sterile Saline Infusion in Healthy Volunteers

Start date: January 12, 2024
Phase: Early Phase 1
Study type: Interventional

The purpose of the study is to evaluate the influence of needle size, injected fluid volume, and rate of fluid on the degree of pain experienced by adult healthy volunteers after subcutaneous infusion of sterile saline.

NCT ID: NCT06194552 Completed - Alzheimer Disease Clinical Trials

A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07

Start date: September 6, 2022
Phase: Phase 1
Study type: Interventional

This is a Phase 1, Randomized, Placebo-Controlled, Modified Parallel Design Multiple Ascending Dose Study of NTRX 07 to Assess Safety and Tolerability and Pharmacokinetics in Adult Healthy Volunteers and Subjects with MCI or Early AD. In addition, an exploratory study of the effect of a high fat meal was conducted.

NCT ID: NCT06194214 Completed - Healthy Clinical Trials

A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy Participants

Start date: March 11, 2021
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the effect of Pirtobrutinib (LOXO-305) on multiple oral doses of digoxin (P-gp substrate) when administered as single and multiple doses by collecting the blood samples and conducting the blood tests to measure how much digoxin is in the bloodstream and how the body handles and eliminates it in healthy participants. The study will also evaluate the safety and tolerability of Pirtobrutinib. Participants will stay in this study for up to 58 days, including screening.

NCT ID: NCT06193694 Completed - Clinical trials for Burnout, Professional

Coaching Program to Address Burnout, Wellness and Professional Development in Early Career Pediatric Surgeons

Start date: February 11, 2022
Phase: N/A
Study type: Interventional

Coaching is a useful tool that uses positivity and goal directed behaviors to increase resiliency and reduce physician burnout. Objectives: Based on the principles of positive psychology, the objectives of the study are to improve early career pediatric surgeon (as defined by years 1-3 out of training) well- being, workplace satisfaction, decrease burnout and improve resiliency of both the coaches and early career pediatric surgeons.

NCT ID: NCT06193304 Completed - Gaucher's Disease Clinical Trials

A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth

Acronym
Start date: August 25, 2014
Phase: Phase 1
Study type: Interventional

A study to assess the absorption of eliglustat through the mouth in healthy subjects and the safety of any systemic exposure resulting from oral surface absorption of eliglustat in healthy subjects.

NCT ID: NCT06193291 Completed - Glucose Tolerance Clinical Trials

Effect of Hot Water Immersion on Heart Rate Variability and Glucose

HWI
Start date: March 2, 2020
Phase: N/A
Study type: Interventional

Heat therapy has been shown to reduce risk of various diseases, including heart disease, alzheimers, and pneumonia, as well as all-cause mortality . A previous study found heating a single hand lowers postprandial blood glucose levels with a magnitude similar to certain exercise interventions such as 40 minutes of slow walking We propose that heating both feet and heating both legs up to the calves will result in similar glucose reductions in a dose response manner.Overview To determine the effect of heating both feet to the ankles and heating both legs to the calves on postprandial blood glucose